Loading clinical trials...
Loading clinical trials...
Arterial hypertension is a major public health issue and is considered to be a new epidemic due to its high mortality and morbidity rates. Elevated blood pressure levels increase the risk of coronary artery disease, heart failure, stroke, chronic kidney disease and death. Dietary nitrate supplementation in the form of beetroot powder extract may offer a more accessible way to increase systemic nitric oxide availability and consequently promote vasodilation in these patients. However, studies are needed to assess its benefits in patients with hypertension.
Methods and Analyses: This is a double-blind, placebo-controlled clinical trial in which patients with hypertension will be randomly assigned to two groups to receive either nitrate powder supplementation or placebo for a duration of 60 days. The primary outcome will be the reduction in blood pressure levels. Secondary outcomes will include systemic microvascular reactivity and quality of life.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
National Institute of Cardiology
Rio de Janeiro, Rio de Janeiro, Brazil
Start Date
June 1, 2024
Primary Completion Date
December 1, 2026
Completion Date
December 1, 2026
Last Updated
July 23, 2025
100
ESTIMATED participants
evaluation of systemic microvascular reactivity
DIAGNOSTIC_TEST
ABPM
DIAGNOSTIC_TEST
beetroot supplement
DIETARY_SUPPLEMENT
Lead Sponsor
National Institute of Cardiology, Laranjeiras, Brazil
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions